Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
PACS Quote, Financials, Valuation and Earnings
Last price:
$12.32
Seasonality move
:
36.65%
Day range:
$12.03 - $12.47
52-week range:
$8.28 - $43.92
Dividend yield:
0%
P/E ratio:
20.01x
P/S ratio:
0.54x
P/B ratio:
3.35x
Volume:
768.9K
Avg. volume:
681.3K
1-year change:
-62.37%
Market cap:
$1.9B
Revenue:
$3.1B
EPS (TTM):
$0.65
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.2B | $2.4B | $3.1B | |
| Revenue Growth (YoY) | -- | -- | -- | 107.62% | 28.47% | |
| Cost of Revenues | -- | -- | $979.2M | $2B | $2.7B | |
| Gross Profit | -- | -- | $187.3M | $400.7M | $447.1M | |
| Gross Profit Margin | -- | -- | 16.06% | 16.54% | 14.37% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $96.8M | $149M | $213.7M | |
| Other Inc / (Exp) | -- | -- | $3.3M | $3.2M | -$536K | |
| Operating Expenses | -- | -- | $104M | $171.3M | $239.3M | |
| Operating Income | -- | -- | $83.4M | $229.4M | $207.8M | |
| Net Interest Expenses | -- | -- | $5.3M | $25.5M | $49.9M | |
| EBT. Incl. Unusual Items | -- | -- | $81.4M | $207M | $157.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $33.5M | $56.5M | $44.4M | |
| Net Income to Company | -- | -- | $47.9M | $150.5M | $112.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8K | |
| Net Income to Common Excl Extra Items | -- | -- | $47.9M | $150.5M | $112.9M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.32 | $1.00 | $0.75 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.32 | $1.00 | $0.75 | |
| Weighted Average Basic Share | -- | -- | $150.2M | $150.2M | $150.2M | |
| Weighted Average Diluted Share | -- | -- | $150.2M | $150.2M | $150.2M | |
| EBITDA | -- | -- | $93.9M | $254.9M | $232.9M | |
| EBIT | -- | -- | $86.7M | $232.6M | $207.2M | |
| Revenue (Reported) | -- | -- | $1.2B | $2.4B | $3.1B | |
| Operating Income (Reported) | -- | -- | $83.4M | $229.4M | $207.8M | |
| Operating Income (Adjusted) | -- | -- | $86.7M | $232.6M | $207.2M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $760.7M | $981.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $642.3M | $828M | |
| Gross Profit | -- | -- | -- | $118.4M | $153.9M | |
| Gross Profit Margin | -- | -- | -- | 15.56% | 15.67% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $62.7M | $144.4M | |
| Other Inc / (Exp) | -- | -- | -- | -$2.6M | -$3.9M | |
| Operating Expenses | -- | -- | -- | $68.9M | $153.2M | |
| Operating Income | -- | -- | -- | $49.5M | $710K | |
| Net Interest Expenses | -- | -- | -- | $15.3M | $9.2M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $31.6M | -$12.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $10.4M | -$1.5M | |
| Net Income to Company | -- | -- | -- | $21.2M | -$10.9M | |
| Minority Interest in Earnings | -- | -- | -- | -$2K | -$2K | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $21.2M | -$10.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.14 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.14 | -$0.07 | |
| Weighted Average Basic Share | -- | -- | -- | $150.2M | $149.5M | |
| Weighted Average Diluted Share | -- | -- | -- | $150.2M | $149.5M | |
| EBITDA | -- | -- | -- | $53.1M | $5.6M | |
| EBIT | -- | -- | -- | $46.9M | -$3.2M | |
| Revenue (Reported) | -- | -- | -- | $760.7M | $981.8M | |
| Operating Income (Reported) | -- | -- | -- | $49.5M | $710K | |
| Operating Income (Adjusted) | -- | -- | -- | $46.9M | -$3.2M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $3.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $2.9B | |
| Gross Profit | -- | -- | -- | -- | $531.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $313.4M | |
| Other Inc / (Exp) | -- | -- | -- | -$2.2M | $2.4M | |
| Operating Expenses | -- | -- | -- | -- | $342.1M | |
| Operating Income | -- | -- | -- | -- | $189.5M | |
| Net Interest Expenses | -- | -- | -- | $25.9M | $50.5M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $141.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $44.3M | |
| Net Income to Company | -- | -- | -- | -- | $97.1M | |
| Minority Interest in Earnings | -- | -- | -- | -$3K | -$7K | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $97M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $0.65 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $0.65 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | $220.5M | |
| EBIT | -- | -- | -- | -- | $191.9M | |
| Revenue (Reported) | -- | -- | -- | -- | $3.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | $189.5M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $191.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.5B | $1.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $1.2B | $1.6B | -- | |
| Gross Profit | -- | -- | $243M | $288.6M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $122.1M | $191.3M | -- | |
| Other Inc / (Exp) | -- | -- | -$2.2M | $4.6M | -- | |
| Operating Expenses | -- | -- | $134.1M | $208M | -- | |
| Operating Income | -- | -- | $108.8M | $80.7M | -- | |
| Net Interest Expenses | -- | -- | $25.9M | $24.6M | -- | |
| EBT. Incl. Unusual Items | -- | -- | $80.7M | $60.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $21.9M | $22.4M | -- | |
| Net Income to Company | -- | -- | $58.8M | $38.2M | -- | |
| Minority Interest in Earnings | -- | -- | -$3K | -$4K | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $58.8M | $38.2M | -- | |
| Basic EPS (Cont. Ops) | -- | -- | $0.39 | $0.26 | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.39 | $0.26 | -- | |
| Weighted Average Basic Share | -- | -- | $300.3M | $297.2M | -- | |
| Weighted Average Diluted Share | -- | -- | $300.3M | $297.2M | -- | |
| EBITDA | -- | -- | $118.6M | $101.9M | -- | |
| EBIT | -- | -- | $106.6M | $85.3M | -- | |
| Revenue (Reported) | -- | -- | $1.5B | $1.9B | -- | |
| Operating Income (Reported) | -- | -- | $108.8M | $80.7M | -- | |
| Operating Income (Adjusted) | -- | -- | $106.6M | $85.3M | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $58.3M | $73.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $370.9M | $547.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $32.8M | $48.7M | |
| Total Current Assets | -- | -- | -- | $511.2M | $722.1M | |
| Property Plant And Equipment | -- | -- | -- | $1.8B | $2.6B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $55.2M | $59M | |
| Other Intangibles | -- | -- | -- | $6.3M | $6.3M | |
| Other Long-Term Assets | -- | -- | -- | $113.6M | $140M | |
| Total Assets | -- | -- | -- | $2.5B | $3.5B | |
| Accounts Payable | -- | -- | -- | $110.6M | $140.9M | |
| Accrued Expenses | -- | -- | -- | $154.3M | $188.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $61.4M | $16.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $121.1M | $110.4M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $483.9M | $456.9M | |
| Long-Term Debt | -- | -- | -- | $438.3M | $715.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $2.4B | $3.4B | |
| Common Stock | -- | -- | -- | $129K | $129K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | $63.6M | $96.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $5M | $5.6M | |
| Total Equity | -- | -- | -- | $68.7M | $101.7M | |
| Total Liabilities and Equity | -- | -- | -- | $2.5B | $3.5B | |
| Cash and Short Terms | -- | -- | -- | $58.3M | $73.4M | |
| Total Debt | -- | -- | -- | $499.7M | $732.5M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $73.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $610.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | $66.3M | |
| Total Current Assets | -- | -- | -- | -- | $800.6M | |
| Property Plant And Equipment | -- | -- | -- | -- | $2.9B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | $118.1M | |
| Total Assets | -- | -- | -- | -- | $3.9B | |
| Accounts Payable | -- | -- | -- | -- | $125.7M | |
| Accrued Expenses | -- | -- | -- | -- | $213.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $15.7M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $113.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $468.1M | |
| Long-Term Debt | -- | -- | -- | -- | $475.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $3.3B | |
| Common Stock | -- | -- | -- | -- | $152K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $6.1M | |
| Total Equity | -- | -- | -- | -- | $578.2M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $3.9B | |
| Cash and Short Terms | -- | -- | -- | -- | $73.4M | |
| Total Debt | -- | -- | -- | -- | $490.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $47.9M | $150.5M | $112.9M | |
| Depreciation & Amoritzation | -- | -- | $7.2M | $22.3M | $25.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -$40.1M | -$114.6M | -$179.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $57.6M | $92.6M | $63.7M | |
| Capital Expenditures | -- | -- | $203.8M | $78.2M | $172.8M | |
| Cash Acquisitions | -- | -- | -$15.7M | -- | -$2.6M | |
| Cash From Investing | -- | -- | -$218.6M | -$75.3M | -$172.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$53.8M | -$60.3M | -$80.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $622.4M | $242.4M | $1.3B | |
| Long-Term Debt Repaid | -- | -- | -$386.6M | -$173.1M | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $3.2M | $587K | |
| Cash From Financing | -- | -- | $182M | $12.4M | $129.6M | |
| Beginning Cash (CF) | -- | -- | $47.5M | $68.6M | $98.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $21.1M | $29.6M | $20.5M | |
| Ending Cash (CF) | -- | -- | $68.6M | $98.2M | $118.7M | |
| Levered Free Cash Flow | -- | -- | -$146.2M | $14.4M | -$109.1M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $21.2M | -$10.9M | |
| Depreciation & Amoritzation | -- | -- | -- | $6.2M | $8.8M | |
| Stock-Based Compensation | -- | -- | -- | -- | $90.9M | |
| Change in Accounts Receivable | -- | -- | -- | -$47.3M | $27.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$21.1M | $34.8M | |
| Capital Expenditures | -- | -- | -- | $10.9M | $111.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$9.7M | -$121M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$25.2M | -$16.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $416.4M | $171M | |
| Long-Term Debt Repaid | -- | -- | -- | -$414.7M | -$465.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$33.1M | |
| Cash From Financing | -- | -- | -- | -$23.5M | $70.7M | |
| Beginning Cash (CF) | -- | -- | -- | $134.9M | $93.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$54.3M | -$15.4M | |
| Ending Cash (CF) | -- | -- | -- | $80.5M | $77.9M | |
| Levered Free Cash Flow | -- | -- | -- | -$32M | -$76.7M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $97.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $28.7M | |
| Stock-Based Compensation | -- | -- | -- | -- | $90.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$147.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | $151.8M | |
| Capital Expenditures | -- | -- | -- | $69M | $269.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -$5.1M | |
| Cash From Investing | -- | -- | -- | -- | -$306.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$43.7M | -$77.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $821.8M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $96.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$58.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -$117.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $58.8M | $38.2M | -- | |
| Depreciation & Amoritzation | -- | -- | $12M | $16.7M | -- | |
| Stock-Based Compensation | -- | -- | -- | $90.9M | -- | |
| Change in Accounts Receivable | -- | -- | -$86.5M | -$60.9M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $58.2M | $93.6M | -- | |
| Capital Expenditures | -- | -- | $69M | $200.7M | -- | |
| Cash Acquisitions | -- | -- | -- | -$5.1M | -- | |
| Cash From Investing | -- | -- | -$67.3M | -$239.6M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$43.7M | -$33.7M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $494.1M | $327.8M | -- | |
| Long-Term Debt Repaid | -- | -- | -$459M | -$569.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$33.1M | -- | |
| Cash From Financing | -- | -- | -$8.6M | $105.2M | -- | |
| Beginning Cash (CF) | -- | -- | $233.1M | $212M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$17.7M | -$40.9M | -- | |
| Ending Cash (CF) | -- | -- | $215.4M | $171.1M | -- | |
| Levered Free Cash Flow | -- | -- | -$10.7M | -$107.1M | -- | |
Get PACS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PACS
Sector
P/E ratio
20.01x
23.88x
PEG ratio
--
0.00x
P/B ratio
3.35x
1.80x
Price / LTM sales
0.54x
1.65x
Growth Metrics
PACS
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
$0.47
-$0.20
Profitability
PACS
Sector
Profitability FY 2023
$447.1M
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Jul
21
Estimated Next Earnings Date
Feb
6
Balance Sheet
PACS
Sector
Total cash
$73.4M
$35.5M
Short term investments
--
$29.7M
Total assets
$3.5B
$106.9M
Long term debt
$490.9M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
